Gene · 191
AHCY: adenosylhomocysteinase
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AHCY: adenosylhomocysteinase. Genes, record 191. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/191
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P23526 | Adenosylhomocysteinase | 432 | 10 | Ensembl, GeneID, HGNC |
Source UniProt
Patents47
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 303 | P23526 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36674 | P23526 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 395 | P23526 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 276 | P23526 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4327 | P23526 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 276 | P23526 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 395 | P23526 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 2763 | P23526 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4327 | P23526 | Espacenet |
| JP 2023521663 A | 2023-05-25 | 302 | P23526 | Espacenet |
1 to 10 of 47
See all 47 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,143
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AHCY papers | Newest fiscal year |
|---|---|---|---|
| P30CA023168 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 4 | 2025 |
| P30DK056350 | Nutrition Obesity Research Center (NORC) | 4 | 2025 |
| R01GM117275 | Protein N-terminal Methylation Mechanisms and Inhibition | 4 | 2025 |
| P30CA006516 | Dana-Farber/Harvard Cancer Center | 3 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 3 | 2025 |
| P50AA022538 | Center for Alcohol Research in Epigenetics | 3 | 2025 |
| R01AI127793 | Neisseria gonorrhoeae metal transporters that subvert nutritional immunity | 3 | 2025 |
1 to 10 of 1,143Source NIH's project files
See all 1,143 nih grantsPapers2,143
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic-cell-death gene trio predicts survival and cuproptosis sensitivity in colorectal cancer. | J Gastrointest Oncol | 2026 | 42703393 | PubTator, text mining | PubMed |
| Hydration at C5'-C6' double bond of adenosine substrates by S-adenosyl-L-homocysteine hydrolase. | Nucleosides Nucleotides Nucleic Acids | 2026 | 42695797 | PubTator, text mining | PubMed |
| Integrated bulk and single-cell transcriptomics unveil the role of AHCY in cell cycle regulation of endometrial cancer. | Front Oncol | 2026 | 42694123 | PubTator, text mining | PubMed |
| Distribution of luxS and production of autoinducer-2 among gut Bacteroidales. | bioRxiv | 2026 | 42619800 | PubTator, text mining | PubMed |
| S-Adenosyl-L-Homocysteine Hydrolase (SAHH): Structure, Function, and Applications. | Biomolecules | 2026 | 42509803 | PubTator, text mining | PubMed |
| Integrated proteomics and machine learning for identifying candidate serum biomarkers in acute myocardial infarction-complicated cardiogenic shock: a prospective exploratory study. | Clin Proteomics | 2026 | 42477545 | PubTator, text mining | PubMed |
| Disruption of methionine metabolism drives erythroid cell fate reprogramming by remodeling the H3K4me3 landscape. | J Clin Invest | 2026 | 42446929 | PubTator, text mining | PubMed |
| Nutrigenomic regulation of one-carbon metabolism and the circadian clock in health and disease. | J Biochem | 2026 | 42383762 | PubTator, text mining | PubMed |
| DZNep: A Methyltransferase Modulator for Disease Mitigation. | Environ Mol Mutagen | 2026 | 42345323 | PubTator, text mining | PubMed |
| Multifaceted anti-infective efficacy of Alstonia scholaris (Mizoram chemotype) against fungal, malarial, and intestinal helminth pathogens: in vitro validation and molecular docking insights. | Vet World | 2026 | 42344326 | PubTator, text mining | PubMed |
1 to 10 of 2,143
See all 2,143 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/191
GET https://conductscience.org/api/genes/v1/191/patents?page=2